Breaking News Instant updates and real-time market news.

SNY

Sanofi

$48.12

-0.06 (-0.12%)

12:25
07/17/17
07/17
12:25
07/17/17
12:25

Sanofi Pasteur ships first flu vaccine doses for 2017-2018 season

Sanofi Pasteur, the vaccines unit of Sanofi, announced that its first doses of the Fluzone portfolio for the 2017-2018 influenza season have been released by the U.S. Food and Drug Administration. Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70M total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.

  • 17

    Jul

SNY Sanofi
$48.12

-0.06 (-0.12%)

06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/12/17
LEER
06/12/17
NO CHANGE
Target $493
LEER
Outperform
Regeneron's Dupixent tracking well above consensus, says Leerink
Leerink analyst Geoffrey Porges says prescription trends suggest Regeneron (REGN) and Sanofi's (SNY) Dupixent will "comfortably exceed" current sell-side consensus expectations for this quarter and year. After 10 weeks, the prescription launch trajectory "remains very robust," Porges tells investors in a research note. The analyst views his Q2 sales estimate of $31M, versus the $16M consensus, as "reasonable," and feels full year sales of $200M-300M, versus the consensus of $135-$140M, is likely. He reiterates an Outperform rating on Regeneron shares.
06/27/17
06/27/17
NO CHANGE

Large cap pharma could benefit from upcoming executive order, says Wells Fargo
Wells Fargo says that, based on press reports, large cap pharma could benefit from President Trump's upcoming executive order on drug pricing. The firm says the articles indicate that the order will not create major reforms or do anything to lower consumers' costs or solve current pricing issues. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06/27/17
FBCO
06/27/17
NO CHANGE
FBCO
Outperform
Alnylam price target raised to $96 from $90 at Credit Suisse
Credit Suisse analyst Alethia Young increased her probability of success for Alnylam's (ALNY) givosian in porphyria to 60% from 40% and keeps an estimate of unadjusted peak sales of $475M, while also noting that the fact that Sanofi (SNY) did not opt into the porphyria program, meaning Alnylam receives full economics. Given the higher chances ascribed to success, Young raised her price target on Alnylam to $96 from $90 and keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

COH

Coach

$48.08

-0.07 (-0.15%)

08:52
07/21/17
07/21
08:52
07/21/17
08:52
Upgrade
Coach rating change  »

Coach upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INDB

Independent Bank

$66.35

-0.35 (-0.52%)

08:52
07/21/17
07/21
08:52
07/21/17
08:52
Upgrade
Independent Bank rating change  »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

AKBA

Akebia

, MACK

Merrimack

$1.30

0.02 (1.56%)

08:51
07/21/17
07/21
08:51
07/21/17
08:51
Periodicals
Former Akebia employee faces losing bail in insider trading case, Reuters says »

Schultz Chan, former…

AKBA

Akebia

MACK

Merrimack

$1.30

0.02 (1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$20.60

0.75 (3.78%)

08:51
07/21/17
07/21
08:51
07/21/17
08:51
Initiation
AMC Entertainment initiated  »

AMC Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 05

    Sep

SIX

Six Flags

$56.28

-1.01 (-1.76%)

08:50
07/21/17
07/21
08:50
07/21/17
08:50
Initiation
Six Flags initiated  »

Six Flags initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

LYV

Live Nation

$36.38

-0.01 (-0.03%)

08:50
07/21/17
07/21
08:50
07/21/17
08:50
Initiation
Live Nation initiated  »

Live Nation initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNP

Union Pacific

$106.14

-1.7 (-1.58%)

08:50
07/21/17
07/21
08:50
07/21/17
08:50
Recommendations
Union Pacific analyst commentary  »

Market ignorning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

MTN

Vail Resorts

$206.11

0.09 (0.04%)

08:50
07/21/17
07/21
08:50
07/21/17
08:50
Initiation
Vail Resorts initiated  »

Vail Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$26.69

-0.25 (-0.93%)

08:49
07/21/17
07/21
08:49
07/21/17
08:49
Hot Stocks
Breaking Hot Stocks news story on General Electric »

General Electric down 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

  • 02

    Oct

GPC

Genuine Parts

$81.69

-1.27 (-1.53%)

08:47
07/21/17
07/21
08:47
07/21/17
08:47
Upgrade
Genuine Parts rating change  »

Genuine Parts upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$67.02

-0.42 (-0.62%)

08:46
07/21/17
07/21
08:46
07/21/17
08:46
Hot Stocks
Schlumberger says expects to double SPM revenue over next two years »

Says has invested $4.3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

GE

General Electric

$26.69

-0.25 (-0.93%)

08:45
07/21/17
07/21
08:45
07/21/17
08:45
Hot Stocks
General Electric CFO says 'trending to bottom end' of $1.60-$1.70 FY17 EPS view »

GE CFO Jeff Bornstein…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

  • 02

    Oct

ITW

Illinois Tool Works

$147.12

-0.56 (-0.38%)

08:45
07/21/17
07/21
08:45
07/21/17
08:45
Technical Analysis
Technical Earnings Preview: Illinois Tool Works in uptrend ahead of news »

The shares have been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

XRT

S&P Retail Index SPDR

$40.59

0.09 (0.22%)

, PAA

Plains All American

$26.47

-0.16 (-0.60%)

08:45
07/21/17
07/21
08:45
07/21/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

XRT

S&P Retail Index SPDR

$40.59

0.09 (0.22%)

PAA

Plains All American

$26.47

-0.16 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 08

    Nov

SLB

Schlumberger

$67.02

-0.42 (-0.62%)

08:41
07/21/17
07/21
08:41
07/21/17
08:41
Hot Stocks
Schlumberger says all U.S. product lines profitable in Q2 »

Says expect high demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

HIMX

Himax

$8.86

0.34 (3.99%)

08:41
07/21/17
07/21
08:41
07/21/17
08:41
Downgrade
Himax rating change  »

Himax downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 05

    Sep

SLM

Sallie Mae

$10.98

-0.83 (-7.03%)

08:41
07/21/17
07/21
08:41
07/21/17
08:41
Recommendations
Sallie Mae analyst commentary  »

Sallie Mae shares should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$67.02

-0.42 (-0.62%)

08:38
07/21/17
07/21
08:38
07/21/17
08:38
Hot Stocks
Schlumberger says 'confident' in delivering free cash flow target for 2017 »

Comments from Q2 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

EXPI

eXp World Holdings

$2.95

-0.04 (-1.34%)

08:36
07/21/17
07/21
08:36
07/21/17
08:36
Initiation
eXp World Holdings initiated  »

eXp World Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CXDC

China XD Plastics

$4.70

-0.025 (-0.53%)

08:35
07/21/17
07/21
08:35
07/21/17
08:35
Hot Stocks
China XD Plastics signs investment agreements for $614M in Harbin, China »

China XD Plastics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAAP

Advanced Accelerator

$41.13

0.56 (1.38%)

08:35
07/21/17
07/21
08:35
07/21/17
08:35
Hot Stocks
Advanced Accelerator: CHMP opinion recommending approval of 177Lu oxodotreotide »

Advanced Accelerator…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNB

F.N.B.

$13.59

-0.56 (-3.96%)

, YDKN

Acquired by FNB

08:35
07/21/17
07/21
08:35
07/21/17
08:35
Recommendations
F.N.B., Acquired by FNB analyst commentary  »

F.N.B. weakness overdone,…

FNB

F.N.B.

$13.59

-0.56 (-3.96%)

YDKN

Acquired by FNB

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OFG

OFG Bancorp

$9.85

-0.1 (-1.01%)

08:34
07/21/17
07/21
08:34
07/21/17
08:34
Earnings
OFG Bancorp reports Q2 EPS 30c, consensus 27c »

OFG Bancorp reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

ENDP

Endo

$12.32

0.24 (1.99%)

08:32
07/21/17
07/21
08:32
07/21/17
08:32
Hot Stocks
Endo closing Huntsville manufacturing and distribution facilities »

Endo will be ceasing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

ADS

Alliance Data

$238.62

-24.91 (-9.45%)

08:30
07/21/17
07/21
08:30
07/21/17
08:30
Recommendations
Alliance Data analyst commentary  »

Alliance Data weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.